Inhibition of angiogenesis: A novel antitumor mechanism of the herbal compound arctigenin

Anti-Cancer Drugs

Volumn 24, Issue 8, 2013, Pages 781-791

  Gu, Yuan ^a   Scheuer, Claudia ^a   Feng, Dilu ^a   Menger, Michael D ^a   Laschke, Matthias W ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

angiogenesis; arctigenin; dorsal skinfold chamber; intravital fluorescence microscopy; tumor; vascularization

Indexed keywords

ANGIOGENESIS INHIBITOR; ARCTIGENIN; COLLAGEN TYPE 4; CYCLINE; PROTEIN SERINE THREONINE KINASE; SCLEROPROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKINFOLD; TUMOR GROWTH; TUMOR SPHEROID; TUMOR VASCULARIZATION; VASCULAR RING;

ANGIOGENESIS INHIBITORS; ANGIOGENIC PROTEINS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FURANS; HUMANS; IMMUNOHISTOCHEMISTRY; LIGNANS; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHYTOTHERAPY; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TIME FACTORS; TISSUE CULTURE TECHNIQUES; TUMOR BURDEN;

EID: 84881044550     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0b013e328362fb84     Document Type: Article

References (35)

1. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004; 56:549-580.
2. Laschke MW, Harder Y, Amon M, Martin I, Farhadi J, Ring A, et al. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 2006; 12:2093-2104.
3. Zetter BR. Angiogenesis and tumor metastasis. Annu Rev Med 1998; 49:407-424.
4. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002; 29:15-18.
5. Swarup V, Ghosh J, Mishra MK, Basu A. Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan. J Antimicrob Chemother 2008; 61:679-688.
6. Susanti S, Iwasaki H, Itokazu Y, Nago M, Taira N, Saitoh S, et al. Tumor specific cytotoxicity of arctigenin isolated from herbal plant Arctium lappa L. J Nat Med 2012; 66:614-621.
7. Jeong JB, Hong SC, Jeong HJ, Koo JS. Arctigenin induces cell cycle arrest by blocking the phosphorylation of Rb via the modulation of cell cycle regulatory proteins in human gastric cancer cells. Int Immunopharmacol 2011; 11:1573-1577.
8. Hirose M, Yamaguchi T, Lin C, Kimoto N, Futakuchi M, Kono T, et al. Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats. Cancer Lett 2000; 155:79-88.
9. Takasaki M, Konoshima T, Komatsu K, Tokuda H, Nishino H. Anti-tumor-promoting activity of lignans from the aerial part of Saussurea medusa. Cancer Lett 2000; 158:53-59.
10. Awale S, Lu J, Kalauni SK, Kurashima Y, Tezuka Y, Kadota S, et al. Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res 2006; 66:1751-1757.
11. Kim JY, Hwang JH, Cha MR, Yoon MY, Son ES, Tomida A, et al. Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity. J Cell Physiol 2010; 224:33-40.
12. Vajkoczy P, Ullrich A, Menger MD. Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation. Neoplasia 2000; 2:53-61.
13. Kollmar O, Rupertus K, Scheuer C, Nickels RM, Haberl GC, Tilton B, et al. CXCR4 and CXCR7 regulate angiogenesis and CT26.WT tumor growth independent from SDF-1. Int J Cancer 2010; 126:1302-1315.
14. Laschke MW, Vollmar B, Menger MD. The dorsal skinfold chamber: window into the dynamic interaction of biomaterials with their surrounding host tissue. Eur Cell Mater 2011; 22:147-164.
15. Laschke MW, Giebels C, Nickels RM, Scheuer C, Menger MD. Endothelial progenitor cells contribute to the vascularization of endometriotic lesions. Am J Pathol 2011; 178:442-450.
16. Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N. Angiogenesis assays: a critical overview. Clin Chem 2003; 49:32-40.
17. Cervellati R, Speroni E, Govoni P, Guerra MC, Costa S, Arnold UW, et al. Wulfenia carinthiaca Jacq., antioxidant and pharmacological activities. Z Naturforsch C 2004; 59:255-262.
18. Kang HS, Lee JY, Kim CJ. Anti-inflammatory activity of arctigenin from Forsythiae fructus. J Ethnopharmacol 2008; 116:305-312.
19. Zhao F, Wang L, Liu K. In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway. J Ethnopharmacol 2009; 122:457-462.
20. Charlton JL. Antiviral activity of lignans. J Nat Prod 1998; 61:1447-1451.
21. Gu Y, Qi C, Sun X, Ma X, Zhang H, Hu L, et al. Arctigenin preferentially induces tumor cell death under glucose deprivation by inhibiting cellular energy metabolism. Biochem Pharmacol 2012; 84:468-476.
22. Yao X, Zhu F, Zhao Z, Liu C, Luo L, Yin Z. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway. J Cell Biochem 2011; 112:2837-2849.
23. Sun S, Wang X, Wang C, Nawaz A, Wei W, Li J, et al. Arctigenin suppresses unfolded protein response and sensitizes glucose deprivation-mediated cytotoxicity of cancer cells. Planta Med 2011; 77:141-145.
24. Torres Filho IP, Leunig M, Yuan F, Intaglietta M, Jain RK. Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice. Proc Natl Acad Sci USA 1994; 91:2081-2085.
25. Naumov GN, Folkman J, Straume O, Akslen LA. Tumor-vascular interactions and tumor dormancy. APMIS 2008; 116:569-585.
26. Vajkoczy P, Schilling L, Ullrich A, Schmiedek P, Menger MD. Characterization of angiogenesis and microcirculation of high-grade glioma: an intravital multifluorescence microscopic approach in the athymic nude mouse. J Cereb Blood Flow Metab 1998; 18:510-520.
27. Laschke MW, Vorsterman van Oijen AE, Scheuer C, Menger MD. In vitro and in vivo evaluation of the anti-angiogenic actions of 4-hydroxybenzyl alcohol. Br J Pharmacol 2011; 163:835-844.
28. Kawauchi K, Ogasawara T, Yasuyama M, Otsuka K, Yamada O. The PI3K/Akt pathway as a target in the treatment of hematologic malignancies. Anticancer Agents Med Chem 2009; 9:550-559.
29. Karar J, Maity A. PI3K/AKT/mTOR pathway in angiogenesis. Front Mol Neurosci 2011; 4:51.
30. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996; 84:359-369.
31. Laschke MW, Rücker M, Jensen G, Carvalho C, Mülhaupt R, Gellrich NC, et al. Incorporation of growth factor containing Matrigel promotes vascularization of porous PLGA scaffolds. J Biomed Mater Res A 2008; 85:397-407.
32. Kollmar O, Rupertus K, Scheuer C, Junker B, Tilton B, Schilling MK, et al. Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia 2007; 9:862-870.
33. Lee YJ, Karl DL, Maduekwe UN, Rothrock C, Ryeom S, D'Amore PA, et al. Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment. Cancer Res 2010; 70: 8357-8367.
34. Rupertus K, Sperling J, Corsten M, Scheuer C, Nickels RM, Schilling MK, et al. Darbepoetin-alpha enhances hepatectomy-associated stimulation of colorectal liver metastatic growth. Ann Surg 2010; 252:131-141.
35. Elliott NT, Yuan F. A review of three-dimensional in vitro tissue models for drug discovery and transport studies. J Pharm Sci 2011; 100:59-74.